FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904532610> ?p ?o ?g. }

• W2904532610 endingPage "119" @default.
• W2904532610 startingPage "110" @default.
• W2904532610 abstract "A cohort of routine care RA patients in sustained remission had biological DMARD (bDMARDs) tapered according to a treatment guideline. We studied: the proportion of patients whose bDMARD could be successfully tapered or discontinued; unwanted consequences of tapering/discontinuation; and potential baseline predictors of successful tapering and discontinuation. One-hundred-and-forty-three patients (91% receiving TNF inhibitor and 9% a non-TNF inhibitor) with sustained disease activity score (DAS28-CRP)⩽2.6 and no radiographic progression the previous year were included. bDMARD was reduced to two-thirds of standard dose at baseline, half after 16 weeks, and discontinued after 32 weeks. Patients who flared (defined as either DAS28-CRP ⩾ 2.6 and ΔDAS28-CRP ⩾ 1.2 from baseline, or erosive progression on X-ray and/or MRI) stopped tapering and were escalated to the previous dose level. One-hundred-and-forty-one patients completed 2-year follow-up. At 2 years, 87 patients (62%) had successfully tapered bDMARDs, with 26 (18%) receiving two-thirds of standard dose, 39 (28%) half dose and 22 (16%) having discontinued; and 54 patients (38%) were receiving full dose. ΔDAS28-CRP0-2yrs was 0.1((−0.2)-0.4) (median (interquartile range)) and mean ΔTotal-Sharp-Score0-2yrs was 0.01(1.15)(mean(s.d.)). Radiographic progression was observed in nine patients (7%). Successful tapering was independently predicted by: ⩽1 previous bDMARD, male gender, low baseline MRI combined inflammation score or combined damage score. Negative IgM-RF predicted successful discontinuation. By implementing a clinical guideline, 62% of RA patients in sustained remission in routine care were successfully tapered, including 16% successfully discontinued at 2 years. Radiographic progression was rare. Maximum one bDMARDs, male gender, and low baseline MRI combined inflammation and combined damage scores were independent predictors for successful tapering." @default.
• W2904532610 created "2018-12-22" @default.
• W2904532610 creator A5001655196 @default.
• W2904532610 creator A5003830368 @default.
• W2904532610 creator A5009515583 @default.
• W2904532610 creator A5010403338 @default.
• W2904532610 creator A5026015056 @default.
• W2904532610 creator A5026711907 @default.
• W2904532610 creator A5031809207 @default.
• W2904532610 creator A5033668583 @default.
• W2904532610 creator A5038260829 @default.
• W2904532610 creator A5039494261 @default.
• W2904532610 creator A5045316899 @default.
• W2904532610 creator A5047627601 @default.
• W2904532610 creator A5051797698 @default.
• W2904532610 creator A5063586848 @default.
• W2904532610 creator A5072664936 @default.
• W2904532610 creator A5076176735 @default.
• W2904532610 creator A5080684522 @default.
• W2904532610 creator A5084105838 @default.
• W2904532610 creator A5084464553 @default.
• W2904532610 creator A5086180632 @default.
• W2904532610 creator A5091577939 @default.
• W2904532610 date "2018-08-28" @default.
• W2904532610 modified "2023-10-14" @default.
• W2904532610 title "Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care – 2-year outcomes and predictors" @default.
• W2904532610 cites W1962721314 @default.
• W2904532610 cites W2014283931 @default.
• W2904532610 cites W2023621352 @default.
• W2904532610 cites W2025591723 @default.
• W2904532610 cites W2027004865 @default.
• W2904532610 cites W2040515772 @default.
• W2904532610 cites W2048370747 @default.
• W2904532610 cites W2048560619 @default.
• W2904532610 cites W2075327204 @default.
• W2904532610 cites W2107756455 @default.
• W2904532610 cites W2114909821 @default.
• W2904532610 cites W2120393706 @default.
• W2904532610 cites W2128952811 @default.
• W2904532610 cites W2152348310 @default.
• W2904532610 cites W2152553239 @default.
• W2904532610 cites W2155109530 @default.
• W2904532610 cites W2168302513 @default.
• W2904532610 cites W2168751860 @default.
• W2904532610 cites W2487918276 @default.
• W2904532610 cites W2543221315 @default.
• W2904532610 cites W2610308940 @default.
• W2904532610 cites W2611753974 @default.
• W2904532610 cites W4210968471 @default.
• W2904532610 cites W4211019157 @default.
• W2904532610 doi "https://doi.org/10.1093/rheumatology/key244" @default.
• W2904532610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30169706" @default.
• W2904532610 hasPublicationYear "2018" @default.
• W2904532610 type Work @default.
• W2904532610 sameAs 2904532610 @default.
• W2904532610 citedByCount "27" @default.
• W2904532610 countsByYear W29045326102019 @default.
• W2904532610 countsByYear W29045326102020 @default.
• W2904532610 countsByYear W29045326102021 @default.
• W2904532610 countsByYear W29045326102022 @default.
• W2904532610 countsByYear W29045326102023 @default.
• W2904532610 crossrefType "journal-article" @default.
• W2904532610 hasAuthorship W2904532610A5001655196 @default.
• W2904532610 hasAuthorship W2904532610A5003830368 @default.
• W2904532610 hasAuthorship W2904532610A5009515583 @default.
• W2904532610 hasAuthorship W2904532610A5010403338 @default.
• W2904532610 hasAuthorship W2904532610A5026015056 @default.
• W2904532610 hasAuthorship W2904532610A5026711907 @default.
• W2904532610 hasAuthorship W2904532610A5031809207 @default.
• W2904532610 hasAuthorship W2904532610A5033668583 @default.
• W2904532610 hasAuthorship W2904532610A5038260829 @default.
• W2904532610 hasAuthorship W2904532610A5039494261 @default.
• W2904532610 hasAuthorship W2904532610A5045316899 @default.
• W2904532610 hasAuthorship W2904532610A5047627601 @default.
• W2904532610 hasAuthorship W2904532610A5051797698 @default.
• W2904532610 hasAuthorship W2904532610A5063586848 @default.
• W2904532610 hasAuthorship W2904532610A5072664936 @default.
• W2904532610 hasAuthorship W2904532610A5076176735 @default.
• W2904532610 hasAuthorship W2904532610A5080684522 @default.
• W2904532610 hasAuthorship W2904532610A5084105838 @default.
• W2904532610 hasAuthorship W2904532610A5084464553 @default.
• W2904532610 hasAuthorship W2904532610A5086180632 @default.
• W2904532610 hasAuthorship W2904532610A5091577939 @default.
• W2904532610 hasBestOaLocation W29045326101 @default.
• W2904532610 hasConcept C114138010 @default.
• W2904532610 hasConcept C119060515 @default.
• W2904532610 hasConcept C121684516 @default.
• W2904532610 hasConcept C126322002 @default.
• W2904532610 hasConcept C141071460 @default.
• W2904532610 hasConcept C142724271 @default.
• W2904532610 hasConcept C2777226972 @default.
• W2904532610 hasConcept C2777575956 @default.
• W2904532610 hasConcept C2778715236 @default.
• W2904532610 hasConcept C2779722408 @default.
• W2904532610 hasConcept C2780182762 @default.
• W2904532610 hasConcept C41008148 @default.
• W2904532610 hasConcept C71924100 @default.
• W2904532610 hasConcept C72563966 @default.

• next